Journal of Experimental Medicine

Aims & Scope

Since its inception in 1896, the goal of Journal of Experimental Medicine (JEM) has been to publish outstanding and enduring studies in medical biology.

At a time when many leading publishing groups are establishing topic-specific journals, we believe it is critical to complement that approach by offering a distinguished venue for publication of studies that integrate disciplines within the field of pathogenesis.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	10.6
2024	12.60

SJR (SCImago Journal Rank)

Year	Value
2024	5.834

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	503

Journal Rank

Year	Value
2024	220

Journal Citation Indicator

Year	Value
2024	7296

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

  Citation: 4282

  Authors: Gordon J., Andrew J., Yoshiko, Karen, Tatyana, Hiroyuki, Lori J., Nelly, Taku, Michael C., Heidi F., Lynette, Laura, Vincent, Michael R., Beatriz M., Mary, Clive R., Tasuku

• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

  Citation: 4014

  Authors: F, A

• Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor <i>Foxp3 </i>

  Citation: 3811

  Authors: WanJun, Wenwen, Neil, Ke-jian, Li, Nancy, George, Sharon M.

• IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

  Citation: 3252

  Authors: Claire L., Yi, Wendy M., Jeanine, Beth, Jonathan D., Terrill, Robert A., Daniel J.

• Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

  Citation: 3021

  Authors: K, M, N, H, M, S, S, R M

• B lymphocytes secrete antigen-presenting vesicles.

  Citation: 2877

  Authors: G, H W, W, R, C V, C J, H J

• PLAQUE FORMATION AND ISOLATION OF PURE LINES WITH POLIOMYELITIS VIRUSES

  Citation: 2843

  Authors: R., Marguerite

• Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

  Citation: 2809

  Authors: R, J, B, C G, J E

• STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES

  Citation: 2532

  Authors: Oswald T., Colin M., Maclyn

• A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism

  Citation: 2294

  Authors: Janine L., Karima R.R., Carolina V., Jason, Cheng-Ming, Yasmine, Fiona

---